354 related articles for article (PubMed ID: 33091458)
1. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse.
James MH; Fragale JE; O'Connor SL; Zimmer BA; Aston-Jones G
Neuropharmacology; 2021 Feb; 183():108359. PubMed ID: 33091458
[TBL] [Abstract][Full Text] [Related]
2. The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand.
Pantazis CB; James MH; Bentzley BS; Aston-Jones G
Addict Biol; 2020 Jul; 25(4):e12795. PubMed ID: 31297913
[TBL] [Abstract][Full Text] [Related]
3. Activation of Hypocretin-1/Orexin-A Neurons Projecting to the Bed Nucleus of the Stria Terminalis and Paraventricular Nucleus Is Critical for Reinstatement of Alcohol Seeking by Neuropeptide S.
Ubaldi M; Giordano A; Severi I; Li H; Kallupi M; de Guglielmo G; Ruggeri B; Stopponi S; Ciccocioppo R; Cannella N
Biol Psychiatry; 2016 Mar; 79(6):452-62. PubMed ID: 26055195
[TBL] [Abstract][Full Text] [Related]
4. Orexin-1 receptor signaling increases motivation for cocaine-associated cues.
Bentzley BS; Aston-Jones G
Eur J Neurosci; 2015 May; 41(9):1149-56. PubMed ID: 25754681
[TBL] [Abstract][Full Text] [Related]
5. Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect.
Simmons SJ; Gentile TA
Brain Res; 2020 Mar; 1731():146164. PubMed ID: 30796894
[TBL] [Abstract][Full Text] [Related]
6. Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors.
Hopf FW
Neuropharmacology; 2020 May; 168():108013. PubMed ID: 32092435
[TBL] [Abstract][Full Text] [Related]
7. Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats.
James MH; Bowrey HE; Stopper CM; Aston-Jones G
Eur J Neurosci; 2019 Aug; 50(3):2602-2612. PubMed ID: 30240516
[TBL] [Abstract][Full Text] [Related]
8. Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats.
James MH; Stopper CM; Zimmer BA; Koll NE; Bowrey HE; Aston-Jones G
Biol Psychiatry; 2019 Jun; 85(11):925-935. PubMed ID: 30219208
[TBL] [Abstract][Full Text] [Related]
9. The Role of Orexins/Hypocretins in Alcohol Use and Abuse.
Walker LC; Lawrence AJ
Curr Top Behav Neurosci; 2017; 33():221-246. PubMed ID: 27909991
[TBL] [Abstract][Full Text] [Related]
10. Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.
Moorman DE; James MH; Kilroy EA; Aston-Jones G
Brain Res; 2017 Jan; 1654(Pt A):34-42. PubMed ID: 27771284
[TBL] [Abstract][Full Text] [Related]
11. Intra-accumbal orexin-1 receptor inhibition prevents the anxiolytic-like effect of ethanol and leads to increases in orexin-A content and receptor expression.
Morales-Mulia M
Pharmacol Biochem Behav; 2019 Oct; 185():172761. PubMed ID: 31425712
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.
Shariq AS; Rosenblat JD; Alageel A; Mansur RB; Rong C; Ho RC; Ragguett RM; Pan Z; Brietzke E; McIntyre RS
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():1-7. PubMed ID: 30576764
[TBL] [Abstract][Full Text] [Related]
13. Hypocretin/Orexin regulation of dopamine signaling and cocaine self-administration is mediated predominantly by hypocretin receptor 1.
Prince CD; Rau AR; Yorgason JT; España RA
ACS Chem Neurosci; 2015 Jan; 6(1):138-46. PubMed ID: 25496218
[TBL] [Abstract][Full Text] [Related]
14. Orexin/Hypocretin System: Role in Food and Drug Overconsumption.
Barson JR; Leibowitz SF
Int Rev Neurobiol; 2017; 136():199-237. PubMed ID: 29056152
[TBL] [Abstract][Full Text] [Related]
15. Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells.
Yeoh JW; James MH; Adams CD; Bains JS; Sakurai T; Aston-Jones G; Graham BA; Dayas CV
Neuropharmacology; 2019 Aug; 154():22-33. PubMed ID: 30253175
[TBL] [Abstract][Full Text] [Related]
16. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders.
Moorman DE
Psychopharmacology (Berl); 2018 Jun; 235(6):1663-1680. PubMed ID: 29508004
[TBL] [Abstract][Full Text] [Related]
17. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
Tsuneki H; Wada T; Sasaoka T
Pharmacol Ther; 2018 Jun; 186():25-44. PubMed ID: 29289556
[TBL] [Abstract][Full Text] [Related]
18. Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling.
Levy KA; Brodnik ZD; Shaw JK; Perrey DA; Zhang Y; España RA
Psychopharmacology (Berl); 2017 Sep; 234(18):2761-2776. PubMed ID: 28667509
[TBL] [Abstract][Full Text] [Related]
19. Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.
Anderson RI; Moorman DE; Becker HC
Handb Exp Pharmacol; 2018; 248():473-503. PubMed ID: 29526023
[TBL] [Abstract][Full Text] [Related]
20. Effects of Suvorexant, a Dual Orexin/Hypocretin Receptor Antagonist, on Impulsive Behavior Associated with Cocaine.
Gentile TA; Simmons SJ; Watson MN; Connelly KL; Brailoiu E; Zhang Y; Muschamp JW
Neuropsychopharmacology; 2018 Apr; 43(5):1001-1009. PubMed ID: 28741623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
